The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin

Browse by...

Deposit

Highlights

More informations

Title		The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin
Authors		Fontana, Pierre Alberts, P Sakariassen, K S Bounameaux, Henri Meyer, J-P Santana Sorensen, A
Published in		Journal of thrombosis and haemostasis. 2011, vol. 9, no. 10, p. 2109-11
Keywords		Aspirin/pharmacology — Enzyme Inhibitors/pharmacology — Humans — Platelet Aggregation Inhibitors/pharmacology — Receptors, Thromboxane/antagonists & inhibitors — Thromboxane-A Synthase/antagonists & inhibitors
Identifiers		DOI: 10.1111/j.1538-7836.2011.04446.x PMID: 21777369
Full text		Article (Published version) (145 Kb) - Limited access to UNIGE
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine
Research group		Geneva Platelet Group (13)
Citation (ISO format)		FONTANA, Pierre et al. The dual thromboxane receptor antagonist and thromboxane synthase inhibitor EV-077 is a more potent inhibitor of platelet function than aspirin. In: Journal of thrombosis and haemostasis, 2011, vol. 9, n° 10, p. 2109-11. doi: 10.1111/j.1538-7836.2011.04446.x https://archive-ouverte.unige.ch/unige:23987